Contact
Bone Therapeutics

Regulated Information

 

 

Regulated information - Financial

Bone Therapeutics Business Update for the Third Quarter of 2018 - 7 November 2018

Press release:   EN FR

Bone Therapeutics announces half-year results for 2018 - 30 August 2018

Press release:  EN - FR

H1 2018 report :  EN - FR

Bone Therapeutics Reports Full Year 2017 Results - 25 April 2018

Press release: EN - FR

Annual report 2017: EN - FR

Bone Therapeutics Business Update for the Third Quarter of 2017 - 9 November 2017

Press release:  EN FR

Bone Therapeutics announces half-year results for 2017 - 31 August 2017

Press release: EN - FR

H1 2017 report : EN - FR

Bone Therapeutics Business Update for the First Quarter of 2017 - 11 May 2017

Press release:  EN FR

Bone Therapeutics Reports Full Year 2016 Results - 16 March 2017

Press release: EN - FR

Annual report 2016: EN - FR

Bone Therapeutics Business Update for the Third Quarter of 2016 - 8 November 2016

Press release:  EN FR - NL

Bone Therapeutics announces half-year results for 2016 - 30 August 2016

Press release: EN - FR - NL

H1 2016 report : EN - FR

Bone Therapeutics Provides Business Update for the First Quarter of 2016 - 10 May 2016

Press release:  EN FR - NL

Bone Therapeutics Reports Full Year 2015 Results - 29 March 2016

Press release: EN - FR - NL

Annual report 2015: EN - FR

Bone Therapeutics Provides Business Update for the Third Quarter of 2015 - 18 November 2015

Press release:  EN FR - NL

Bone Therapeutics announces half-year results for 2015 - 22 September 2015

Press release:  EN FR - NL

Bone Therapeutics Provides Business Update for the First Quarter 2015 - 15 May 2015

Press release:  EN FR - NL

Bone Therapeutics reports 2014 financial and operational results - 28 April 2015

Press release:  EN FR - NL

Annual report 2014: EN - FR

Prospectus - 21 January 2015

Download

 

Regulated information - Shares and voting rights

Transparency declaration SRIW SA & Sofipôle SA - 4 Decembe 2018

Press release:  EN FR

Transparency declaration S.R.I.W. SA & Sofipôle SA

Information on the total number of voting rights and shares - 14 November 2018

Press release:     EN FR

Information on the total number of voting rights and shares - 10 October 2018

Press release:    EN -   FR  

Information on the total number of voting rights and shares - 12 September 2018

Press release:   EN -    FR   

Information on the total number of voting rights and shares - 22 August 2018

Press release:   EN -   FR  

Information on the total number of voting rights and shares - 11 July 2018

Press release:    EN FR

Information on the total number of voting rights and shares - 6 June 2018

Press release:   EN FR

Information on the total number of voting rights and shares - 28 May 2018

Press release:  EN   -  FR

Information on the total number of voting rights and shares - 4 May 2018

Press release: EN  -  FR

Transparency declaration SRIW SA & Sofipôle SA - 29 March 2018

Press release: EN FR 

Transparency declaration S.R.I.W. SA & Sofipôle SA

Information on the total number of voting rights and shares - 21 March 2018

Press release: EN  -  FR

Transparency declaration Theodorus II SA - 11 October 2016

Press release: EN FR - NL

Transparency declaration Theodorus II SA DOWNLOAD

Transparency declaration SRIW SA & Sofipôle SA - 22 October 2015

Press release: EN FR - NL

Transparency declaration S.R.I.W. SA & Sofipôle SA download

Bone Therapeutics appoints Bank Degroof as Liquidity Provider - 3 August 2015

Press release:  EN FR - NL

Information on the total number of voting rights and shares - 19 February 2015

Press release: EN  -  FR - NL

Transparency declaration - 17 February 2015

Transparency notification received from S.R.I.W. & Sofipôle, Mr J. Reymann, SFPI SA and Theodorus II SA

Press release: EN  -  FR - NL

Transparency declaration S.R.I.W. & Sofipôle Download

Transparency declaraton Mr J. Reymann Download

Transparency declaration SFPI SA Download

Transparency declaration Theodorus II SA Download

Exercise of Over-allotment Option - 11 February 2015

Full Exercise of Over-allotment Option: Total proceeds from the Initial Public Offering increased to €37 million

Press release:  EN  -  FR - NL

 

Regulated information - Bond information

Convertible bonds - 7 March 2018

Press release: EN FR 

Special report of the Board of Directors pursuant to sections 583 and 596 of the BCC

 

Regulated information - Annual General Meeting

Preparatory documents for the Annual General Shareholder Meeting on 13 June 2018 have been made available - 9 May 2018

Press release:   EN - FR

Preparatory documents for the Annual General Shareholder Meeting on 26 May 2017 have been made available - 26 April 2017

Press release:   EN FR - NL

Preparatory documents for the Annual General Shareholder Meeting on 26 May 2016 have been made available - 26 April 2016

Press release:  EN FR - NL

Preparatory documents for the Annual General Shareholder Meeting on 28 May 2015 have been made available - 28 April 2015

Press release:  EN FR - NL